|
WDFY1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.301200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.852500E-02 |
| Normal-vs-Stage2 |
8.056400E-01 |
| Normal-vs-Stage3 |
7.272400E-01 |
| Normal-vs-Stage4 |
8.354800E-01 |
| Stage1-vs-Stage2 |
9.656200E-02 |
| Stage1-vs-Stage3 |
1.372830E-01 |
| Stage1-vs-Stage4 |
2.178800E-01 |
| Stage2-vs-Stage3 |
5.882400E-01 |
| Stage2-vs-Stage4 |
6.902600E-01 |
| Stage3-vs-Stage4 |
9.243200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.580550E-01 |
| Normal-vs-AfricanAmerican |
1.335420E-01 |
| Normal-vs-Asian |
2.674600E-01 |
| Caucasian-vs-AfricanAmerican |
5.315800E-01 |
| Caucasian-vs-Asian |
9.147000E-01 |
| AfricanAmerican-vs-Asian |
6.155800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.024200E-01 |
| Normal-vs-Female |
1.378990E-01 |
| Male-vs-Female |
1.791360E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.789950E-02 |
| Normal-vs-Age(41-60Yrs) |
7.998200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.924200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.497200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.423700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.787900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.123240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.974800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.464200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.142200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.845000E-01 |
| Classical-VS-Follicular |
4.76670000004731E-06 |
| Classical-VS-Other |
1.444210E-01 |
| Classical-VS-Normal |
2.225700E-02 |
| Tall-VS-Follicular |
5.602200E-03 |
| Tall-VS-Other |
1.196980E-01 |
| Tall-VS-Normal |
1.271580E-01 |
| Follicular-VS-Other |
9.936800E-01 |
| Follicular-VS-Normal |
9.939800E-02 |
| Other-VS-Normal |
3.962800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.358000E-01 |
| Normal-vs-N1 |
8.255200E-01 |
| N0-vs-N1 |
9.337600E-01 |
|
|
